A comparison of the performance and impact of breast cancer screening programmes in East Anglia, U.K. and Bouches Du Rhone, France

European Journal of Cancer Part A

Volumn 33, Issue 3, 1997, Pages 429-435

  McCann, J ^a   Wait, S ^b   Seradour B ^b   Day, N ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b TIMONE HOSPITAL   (France)

Author keywords

breast cancer; evaluation; mammography; mass screening; quality assurance; tumour size

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CONTROLLED STUDY; FEMALE; FRANCE; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MASS SCREENING; PRIORITY JOURNAL; SCREENING; TUMOR VOLUME; UNITED KINGDOM;

EID: 0031104885     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(97)89018-1     Document Type: Article

References (24)

1. Feig SA. Decreased breast cancer mortality through mammographic screening: results of clinical trials. Radiology. 167:1988;659-665.
2. Forrest P. Breast Cancer Screening. 1986;HMSO, London.
3. Incidence, mortality and population estimates. 1979-1992;Office of Populations, Censuses and Surveys, London. HMSO.
4. Bentham G, Gale S, Haynes R, Lovett A, Brainard J. Analysis of Small Area Statistics on Morbidity, Mortality and Deprivation for Resource Allocation in East Anglia. 1993;University of East Anglia School of Environmental Sciences.
5. Guenot C. Evaluation des programmes communautaires de dépistages. Santé Publique. 6:1990;62-83.
6. Statistiques des causes médicales de décès du laboratoire SC8. In INSERM, Chiffres et Indicateurs Départemenaux. 1993;48-49.
7. Coudert B, Chaplain G, Milan C, Janoray P. Facteurs déterminant les traitements adjuvants du cancer du sein dans le département de la Côte d'Or entre 1982 et 1990. Registre des cancers gynécologiques de Côte d'Or. Bull Cancer. 83:1996;54-62.
8. Department of Health. Guidelines on the Establishments of a Quality Assurance System for the Radiological Aspects of Mammography Used in Breast Screening. 1988;NHSBSP Publications, Trent Regional Health Authority, Sheffield.
9. Recensement des Populations. 1990;Institut National des Statistiques Economiques, Paris.
10. Bouhnik H, Desquerre-Aufort I, Noël A, Stines J. Recommendations du groupe interdisciplinaire de mammographie (G.I.M.) sur l'assurance de la qualité en mammographie. Revue d'Imagerie Médicale. 6:1994;447-454.
11. Europe Against Cancer. European Guidelines for Quality Assurance in Mammographic Screening. 1992;Commission of European Communities, Brussels.
12. Knuth DE. Sorting and Searching. The Art of Computer Programming. Vol. 3:1973;389-402 Addison-Wesley Publishing Co. Inc. Massachusetts.
13. Jacquemier J, Assada M, Aubert H, et al. Recueil départemental des données histopronostiques en sénologie. Bull Cancer. 79:1992;999-1008.
14. Mamelle N, et al. Réseau Inserm de Santé Publique. Rapport final: méthodologie dévaluation comparative des programmes de dépistage du cancer du sein. 1994;INSERM, Lyon. U265.
15. Peeters PHM, Verbeek ALM, Zielhuis GA, Vooijs GP, Hendriks JHCL, Mravunac M. Breast cancer screening in women over age 50. Acta Radiologica. 31:1990;225-231.
16. Day NE, Williams DRR, Khaw KT. Breast cancer screening programmes: the development of a monitoring and evaluation system. Br J Cancer. 59:1989;954-958.
17. Duffy SW, Tabar L, Fagerberg G, et al. Breast screening prognostic factors and survival results from the Swedish two-county study. Br J Cancer. 64:1991;133-1138.
18. Tabar L, Faberberg G, Duffy S, Day NE, Gad A, Grontoft O. Update of the Swedish two-county program of mammographic screening for breast cancer. Radiol Clin North Am. 30:1992;187-210.
19. Nystrom L, Rutqvist LE, Wall S, et al. Breast cancer screening with mammography: an overview of the Swedish randomised trials. Lancet. 341:1993;973-978.
20. Smart CR, Hendrick RE, Rutledge JH, Smith RA. Benefit of mammography screening in women aged 40 to 49 years: current evidence from randomised trials. Cancer. 75:1995;1619-1626.
21. Van der Maas P, de Koning HJ, van Ineveld BM, et al. The cost-effectiveness of breast cancer screening. Int J Cancer. 43:1989;1055-1060.
22. Secretary of State of Health. The Health of the Nation. A Strategy for Health in England. 1992;HMSO, London.
23. Day NE, McCann J, Camilleri-Ferrante CC, et al. Monitoring interval cancers in breast screening programmes: the East Anglian experience. J Med Screening. 2:1995;180-185.
24. Chamberlain J, Moss SM, Michell M, Johns L. National Health Service breast screening programme results for 1991-1992. Br Med J. 307:1993;353-356.